# Diabetes Discharge Transitional CGM Study (DDT-CGM)

Study · id `cardio:ct-nct04729985` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04729985](<https://clinicaltrials.gov/study/NCT04729985>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04729985

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04729985. Randomized; single masking; primary purpose prevention. Start 2021-06-01 (actual); primary completion 2024-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04729985, source copy `cardio:ctgov-nct04729985-2024-02-26`, retrieved 2026-10-26)
- Started: 2021-06-01 (actual) (ClinicalTrials.gov record NCT04729985, source copy `cardio:ctgov-nct04729985-2024-02-26`, retrieved 2026-10-26)
- Primary completion: 2024-07-01 (anticipated) (ClinicalTrials.gov record NCT04729985, source copy `cardio:ctgov-nct04729985-2024-02-26`, retrieved 2026-10-26)
- Completion: 2024-12-01 (anticipated) (ClinicalTrials.gov record NCT04729985, source copy `cardio:ctgov-nct04729985-2024-02-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04729985, source copy `cardio:ctgov-nct04729985-2024-02-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04729985-2024-02-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Diabetes Discharge Transitional CGM Study (DDT-CGM)
- Acronym: DDT-CGM
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): CGM device with diabetic education, CGM education and a follow up protocol.
- Lead sponsor: Intermountain Health Care, Inc.
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Intermountain Health Care, Inc. (`cardio:org-intermountain-health-care-inc`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 96094805ab5f0e26629b2f99779be53cf242f611699166d0fec0bc1f8456776e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
